Airnexis Therapeutics Inc
Palo Alto, US · Founded 2024 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
AC
Anna ChenDirector
CW
Colin WalshDirector
EC
Evan CaplanDirector
JL
James LiExecutive Officer, Director
MF
Maria FardisExecutive Officer, Director
JC
Jill CarrollDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$62MraisedMar 2026 · 13 investors · BiotechnologyRule 506(b)
▶$62MraisedMar 2026 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anna ChenDirector
- Colin WalshDirector
- Evan CaplanDirector
- James LiExecutive Officer, Director
- Jill CarrollDirector
- Maria FardisExecutive Officer, Director
- Offering amount
- $200M
- Amount sold
- $62M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.